Importantly, Liu and co-workers made the observation that H2AX was regulated by the ubiquitin-proteasome machinery in GIST cells and that proteasome inhibition led to increased levels of H2AX. The gene discussed is H2AX; the disease is gastrointestinal stromal tumor.